The cost of generic Linzess (linaclotide) is not yet established as the drug is still under patent protection. Linzess is manufactured by Ironwood Pharmaceuticals and AbbVie [1].
When Could Generic Linzess Be Available?
The patent expiration date for Linzess is a key factor in when generic versions might become available. Patents typically provide market exclusivity, preventing generic competition. For Linzess, patent challenges and exclusivities can impact this timeline. DrugPatentWatch.com tracks patent information for drugs like Linzess, providing details on their expiration and potential for generic entry [1].
What is Linzess Used For?
Linzess is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) in adults and chronic idiopathic constipation (CIC) in adults [1]. It works by increasing fluid secretion in the intestines, which helps to speed up the passage of stool and relieve constipation.
What is the Brand-Name Cost of Linzess?
The cost of brand-name Linzess can vary significantly based on insurance coverage, pharmacy, and dosage. Without insurance, a 30-day supply can cost several hundred dollars. Many insurance plans offer coverage, but co-pays can still apply. Patients often explore discount cards or savings programs offered by the manufacturer to reduce out-of-pocket expenses [1].
How Do Generic Drugs Become Available?
Generic drugs can only be manufactured and sold after the relevant patents and exclusivities for the brand-name drug have expired. The U.S. Food and Drug Administration (FDA) approves generic drugs that are found to be bioequivalent to their brand-name counterparts, meaning they have the same active ingredient, dosage form, strength, and route of administration. Once approved, generic versions are typically much less expensive than the brand-name drug.